First evaluations of oxygen-ozone therapy in antibiotic-resistant infections


Submitted: 12 January 2016
Accepted: 24 February 2016
Published: 5 April 2016
Abstract Views: 5361
PDF: 2197
HTML: 4691
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Acquired antibiotic resistance represents one of the main restrictions to an effective antibacterial chemotherapy. The continuous growth of the phenomenon draws a therapeutical problem to eradicate infections. Ozone presents known properties, such as antibacterial, antiviral, anti-fungal, anti-inflammatory, analgesic, immunomodulation, and reactivation of microcirculation. Oxygen-ozone therapy has no collateral effects, it is minimally invasive, it is not painful and it does not cause allergic or toxic reactions or drug-drug interactions. Therefore, oxygen-ozone therapy has proved to be useful to control and run out infections in patients with a noted antimicrobial resistant pathology. We are evaluating the best protocol to treat these pathologies, to obtain the most efficient therapeutical response.

Franzini, M., Valdenassi, L., & Ionita, G. (2016). First evaluations of oxygen-ozone therapy in antibiotic-resistant infections. Ozone Therapy, 1(1), 5–7. https://doi.org/10.4081/ozone.2016.5838

Downloads

Download data is not yet available.

Citations